Cholesterol Drug Shows Promise Against COVID-19 A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by SARS-CoV-2 (the virus that causes COVID-19) by up to 70 percent, reveals a study in the laboratory by an international collaboration of researchers. The research team, led by the … Continue reading Research Shows Drug Reduces COVID Infection by Up to 70% – Already FDA Approved for Cholesterol